TrialAIDS (London, England)2018

No neurocognitive advantage for immediate antiretroviral treatment in adults with greater than 500 CD4+ T-cell counts.

Edwina J Wright et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.